Ecosystem Nourishment for Gut Restoration After Fecal Transplantation
Key claim: An early randomized trial is testing whether young-donor fecal microbiome transplantation, a fermented plant-rich high-fiber microbiome rejuvenating diet, or both reduce inflammatory and biological aging markers in adults aged 40 and older.
Abstract
The purpose of this study is to test whether young-donor fecal microbiome transplantation (FMT) and a fermented, plant-rich high-fiber, microbiome rejuvenating diet (MRD) reduce inflammatory and biological aging markers. Participants (≥40 years) will be randomized (1:1:1:1) for 8 weeks with 4-week follow-up to: (A) diet alone, (B) FMT alone, © diet + FMT, or (D) Placebo FMT. We will use rigorously screened young and healthy FMT donors and encapsulated delivery. Outcomes include change from baseline to end of dietary intervention (week 8) in markers of aging and inflammation. Secondary outcomes include defining microbiome engraftment/diversity/function, key metabolites, diet adherence, and quality-of-life.
Why this matters
Most FMT-for-aging signal so far is animal work, donor-selection theorizing, and narrative review; this is one of the first longevity-framed human RCTs to actually randomize young-donor FMT against a defined dietary ‘ecosystem nourishment’ arm in middle-aged adults. The trend of pairing transplantation with a fiber/fermented-food substrate is spreading in longevity clinic protocols ahead of any efficacy readout, so the protocol launch itself is the trend signal — not evidence of benefit.